Your browser is no longer supported. Please, upgrade your browser.
Settings
COLL Collegium Pharmaceutical, Inc. daily Stock Chart
COLL [NASD]
Collegium Pharmaceutical, Inc.
Index- P/E- EPS (ttm)-0.91 Insider Own2.50% Shs Outstand33.33M Perf Week5.06%
Market Cap401.65M Forward P/E37.31 EPS next Y0.32 Insider Trans-16.38% Shs Float31.28M Perf Month-8.23%
Income-30.20M PEG- EPS next Q-0.19 Inst Own- Short Float8.87% Perf Quarter-29.03%
Sales291.20M P/S1.38 EPS this Y52.00% Inst Trans-7.23% Short Ratio7.56 Perf Half Y-35.11%
Book/sh2.59 P/B4.65 EPS next Y351.90% ROA-6.30% Target Price28.14 Perf Year-56.15%
Cash/sh4.05 P/C2.98 EPS next 5Y41.40% ROE-36.40% 52W Range10.55 - 28.91 Perf YTD-29.82%
Dividend- P/FCF3.27 EPS past 5Y-7.60% ROI-20.10% 52W High-58.32% Beta0.43
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin41.00% 52W Low14.22% ATR0.57
Employees266 Current Ratio1.20 Sales Q/Q17.00% Oper. Margin-6.00% RSI (14)47.76 Volatility4.05% 4.32%
OptionableYes Debt/Eq0.13 EPS Q/Q48.70% Profit Margin-10.40% Rel Volume0.54 Prev Close12.20
ShortableYes LT Debt/Eq0.10 EarningsMay 08 AMC Payout- Avg Volume366.81K Price12.05
Recom1.70 SMA202.93% SMA50-10.82% SMA200-23.15% Volume197,173 Change-1.23%
May-03-19Resumed H.C. Wainwright Buy $23
Apr-12-19Resumed Janney Buy $29
Mar-20-19Initiated SunTrust Hold $22
Jan-16-19Reiterated Needham Buy $35 → $33
Mar-08-18Reiterated H.C. Wainwright Buy $21 → $33
Feb-07-18Reiterated Needham Buy $28 → $35
Dec-05-17Reiterated Needham Buy $25 → $28
Sep-11-17Initiated H.C. Wainwright Buy $21
May-11-17Reiterated Needham Buy $28 → $25
Sep-13-16Initiated Gabelli & Co Buy $25
Jun-01-15Initiated Piper Jaffray Overweight $26
Jun-01-15Initiated Needham Buy $28
Jun-01-15Initiated Jefferies Buy $20
May-29-19 08:00AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
May-16-19 07:01PM  Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 10:03PM  Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript Motley Fool +5.05%
01:53PM  Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ? Insider Monkey
11:24AM  Assertio Therapeutics, Inc (ASRT) Q1 2019 Earnings Call Transcript Motley Fool
May-08-19 05:45PM  Collegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:37PM  Collegium Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:01PM  Collegium Reports First Quarter 2019 Financial Results GlobeNewswire
May-06-19 11:54AM  Assertio Therapeutics (ASRT) to Post Q1 Earnings: What's Up? Zacks +5.15%
May-05-19 09:19AM  2 Big Biotech Stock Upgrades: Can They Reach These Targets? Motley Fool
May-01-19 10:33AM  Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Apr-30-19 04:01PM  Collegium to Participate in Upcoming Investor Conferences GlobeNewswire -7.20%
Apr-24-19 04:01PM  Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update GlobeNewswire
Apr-02-19 08:00AM  Collegium Appoints Richard Malamut, M.D., as Chief Medical Officer GlobeNewswire
Apr-01-19 08:00AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
Mar-31-19 09:45AM  Read This Before Buying Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Simply Wall St.
Mar-25-19 09:00AM  Collegium Pharmaceutical (COLL) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-06-19 11:49PM  Assertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-04-19 01:46AM  Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-19 07:14PM  Collegium Pharmaceutical Inc (COLL) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Collegium Reports Fourth-Quarter and Full-Year 2018 Financial Results GlobeNewswire
Feb-20-19 10:31AM  Collegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Feb-15-19 09:30AM  ASRT or COLL: Which Is the Better Value Stock Right Now? Zacks +6.48%
Feb-13-19 08:40AM  Collegium to Host Conference Call to Discuss Fourth Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Feb-12-19 02:03PM  Breakeven On The Horizon For Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Simply Wall St.
Jan-30-19 09:30AM  ASRT vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jan-17-19 07:20AM  Report: Developing Opportunities within Enterprise Products Partners, Antero Midstream Partners LP, Integrated Device Technology, Collegium Pharmaceutical, GAIN Capital, and United Technologies Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-14-19 09:30AM  ASRT vs. COLL: Which Stock Should Value Investors Buy Now? Zacks
Jan-07-19 08:00AM  Collegium Provides Full-Year 2019 Financial Guidance GlobeNewswire -19.55%
Dec-19-18 11:43PM  Do Hedge Funds Love Collegium Pharmaceutical Inc (COLL)? Insider Monkey -8.21%
06:53PM  Edited Transcript of COLL earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-11-18 02:31PM  How Financially Strong Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL)? Simply Wall St.
Nov-26-18 04:44PM  Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Are Hedge Funds Right About This Stock? Insider Monkey
Nov-12-18 07:24AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
Nov-08-18 07:25PM  Collegium Pharmaceutical (COLL) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:21PM  Collegium Pharmaceutical: 3Q Earnings Snapshot Associated Press
04:05PM  Collegium Reports Third Quarter Financial Results GlobeNewswire
08:04AM  Collegium Pharmaceutical Q3 Earnings Preview Benzinga
Nov-01-18 11:28AM  Collegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-29-18 08:00AM  Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER GlobeNewswire
Oct-18-18 08:00AM  Report: Exploring Fundamental Drivers Behind Continental Building Products, Hornbeck Offshore Services, Digi International, Triple-S Management, Collegium Pharmaceutical, and Cardiovascular New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-17-18 08:30AM  Collegium to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Sep-28-18 02:16PM  Collegium to Present at Upcoming Investor Conference GlobeNewswire
Sep-04-18 10:01AM  Collegium Announces Scientific Presentations at PAINWeek 2018 Meeting GlobeNewswire
Aug-24-18 07:30AM  Report: Exploring Fundamental Drivers Behind Fiesta Restaurant Group, Emerge Energy Services LP, Collegium Pharmaceutical, Cutera, Resources Connection, and Spark Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-23-18 11:45PM  Edited Transcript of COLL earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-18 07:30PM  Collegium Pharmaceutical (COLL) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM  Collegium Reports Second Quarter Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
10:16AM  Q2 Earnings Preview Collegium Pharmaceutical Benzinga
Jul-31-18 07:10AM  Complimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks ACCESSWIRE
Jul-20-18 01:06PM  Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Jul-10-18 07:30AM  Collegium Announces Promotion of Scott Dreyer to CCO GlobeNewswire
Jun-28-18 07:50AM  Free Research Reports on Catalent and Three More Generic Drugs Stocks ACCESSWIRE
Jun-26-18 02:55PM  Is Collegium Pharmaceutical Inc (NASDAQ:COLL) A Financially Sound Company? Simply Wall St.
Jun-18-18 07:40AM  New Research: Key Drivers of Growth for Outfront Media, Enel Chile, Banc of California, Northern Dynasty Minerals, Collegium Pharmaceutical, and Petroleo Brasileiro S.A. - Petrobras Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-12-18 04:10PM  Cantor Fitzgerald Out Bullish On Collegium As 'Leading Company' In Pain Management Benzinga +7.13%
Jun-04-18 04:01PM  Collegium Announces CEO Succession GlobeNewswire
May-30-18 04:01PM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
May-14-18 09:52PM  Edited Transcript of COLL earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-11-18 07:00AM  Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks ACCESSWIRE
May-10-18 05:40PM  Why Depomed Inc.'s Shares Soared 23.2% Higher Motley Fool +7.73%
May-09-18 04:14PM  Collegium Pharmaceutical: 1Q Earnings Snapshot Associated Press
04:01PM  Collegium Reports First Quarter Financial Results and Provides Corporate Update GlobeNewswire
09:31AM  Where Collegium Pharmaceutical Inc (NASDAQ:COLL) Stands In Earnings Growth Against Its Industry Simply Wall St.
May-02-18 04:01PM  Collegium to Present at the Deutsche Bank Health Care Conference GlobeNewswire
Apr-20-18 08:01AM  Collegium to Host Conference Call to Discuss First Quarter 2018 Financial Results and Provide Corporate Update GlobeNewswire
Apr-16-18 06:14AM  Collegium Pharmaceutical, Inc. (COLL) Sees Hammer Chart Pattern: Time to Buy? Zacks
Apr-04-18 04:01PM  Collegium to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
Mar-19-18 08:00AM  Collegium Announces the Appointment of Shirley Kuhlmann as General Counsel GlobeNewswire
Mar-16-18 08:06AM  Collegium to Present at Upcoming Investor Conferences GlobeNewswire
Mar-10-18 11:03AM  Top Growth Stocks To Buy Now Simply Wall St.
Mar-09-18 09:15AM  Trump Tones Down Tariff Talk Zacks -8.25%
Mar-08-18 04:48PM  This Biotech Flirts With Breakout Amid Battle With Opioid Makers Investor's Business Daily +22.94%
Mar-07-18 04:09PM  Collegium Pharmaceutical posts 4Q loss Associated Press
04:01PM  Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update GlobeNewswire
12:30PM  Collegium Pharmaceutical, Inc. to Host Earnings Call ACCESSWIRE
09:55AM  A Preview Of Collegium Pharmaceutical Q4 Earnings Benzinga
Feb-26-18 04:01PM  Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update GlobeNewswire
Feb-14-18 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within Electronic Arts, The Goodyear Tire & Rubber, Wendy's, Collegium Pharmaceutical, IAC/InterActiveCorp, and Endurance International Group New Research Emphasizes Economic Growth GlobeNewswire
Jan-18-18 09:25AM  3 Top-Ranked Drug Stocks That Are Broker Favorites InvestorPlace
07:02AM  3 Top-Ranked Drug Stocks that are Broker Favorites Zacks
Jan-11-18 10:54AM  Nektar Notches New Highs As Stock Triples In Two Months Forbes +7.30%
Jan-10-18 11:39AM  Harry Boxers three health-care stocks to watch today MarketWatch
09:01AM  Collegium Announces Closing of Agreement to License Rights to Commercialize Nucynta Franchise GlobeNewswire
Jan-01-18 09:11AM  Collegium Pharmaceutical, Inc. :COLL-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-12-17 11:55AM  Collegium to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference GlobeNewswire
Dec-11-17 08:36AM  Sage Therapeutics Soars: Stock Adds 7.1% in Session Zacks
08:31AM  Valeant (VRX) in Focus: Stock Moves 11.7% Higher Zacks
Dec-06-17 12:05PM  Depomed Executes an Exit Strategy for Its Opioid Drug Motley Fool
Dec-05-17 02:29PM  How Two Drugmakers Rocketed On A Deal That Sees One Exit Opioid Sales Investor's Business Daily
12:04PM  Here's Why Collegium Pharmaceutical Rose as Much as 23.5% Today Motley Fool
Dec-04-17 08:46PM  Barron's After Hours: Collegium Jumps, Ascena Retail Slumps, Cleveland-Cliffs Falls Barrons.com
05:03PM  Depomed farms out Nucynta sales, will lay off 40% of company MarketWatch
04:30PM  Collegium to License Rights to Commercialize Nucynta Franchise GlobeNewswire
Nov-30-17 08:30AM  Detailed Research: Economic Perspectives on Electronic Arts, The Goodyear Tire & Rubber, Wendy's, Collegium Pharmaceutical, IAC/InterActiveCorp, and Endurance International Group What Drives Growth in Today's Competitive Landscape GlobeNewswire +8.83%
Nov-27-17 09:43AM  Top Ranked Momentum Stocks to Buy for November 27th Zacks -7.67%
Nov-22-17 04:18PM  Why Collegium Pharmaceutical Shares Are Tumbling 12.9% Today Motley Fool -12.27%
08:42AM  Collegium to Present at the 29th Annual Piper Jaffray Healthcare Conference GlobeNewswire
06:53AM  Top Ranked Momentum Stocks to Buy for November 22nd Zacks
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, heating, and injecting. The company offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. Furhter, it offers Nucynta ER, an extended release formulation of tapentadol for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, such as neuropathic pain related to diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate release formulation of tapentadol that is indicated for the management of moderate to severe acute pain in adults. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ciaffoni JosephPresident and CEOJun 03Sale11.597,43686,183180,222Jun 04 04:17 PM
Ciaffoni JosephPresident and CEOMay 31Sale11.525,85167,404190,755Jun 04 04:17 PM
Heffernan Michael ThomasDirectorMay 15Sale12.8425,000321,042182,069May 17 04:04 PM
Heffernan Michael ThomasDirectorApr 15Sale15.0925,000377,366202,362Apr 17 04:24 PM
Heffernan Michael ThomasDirectorMar 15Sale17.1725,000429,250227,362Mar 19 05:36 PM
Heffernan Michael ThomasDirectorFeb 15Sale14.8125,000370,224252,362Feb 20 04:17 PM
Heffernan Michael ThomasDirectorJan 15Sale15.5625,000389,000286,000Jan 17 04:16 PM
Heffernan Michael ThomasDirectorDec 17Sale18.1825,000454,491311,000Dec 18 05:09 PM
Heffernan Michael ThomasDirectorNov 15Sale16.6025,000415,122336,000Nov 16 04:19 PM
Heffernan Michael ThomasDirectorOct 15Sale16.5325,000413,250361,000Oct 17 04:27 PM
Brannelly PaulExecutive Vice President & CFOJun 21Sale27.9210,000279,165123,436Jun 22 06:25 PM